There is evidence that tumors with MSI develop from flat lesions via mutation in RNF43 (serrated adenoma pathway) rather than the adenoma to adenocarcinoma pathway, which is associated with gatekeeper mutations in the APC gene [27]. This evidence concerns the gene RNF43 and adenocarcinoma.